Antimicrobial activity of Hippobromus pauciflorus: A medicinal plant used for the treatment of eye infections in the Eastern Cape, South Africa

Pharmaceutical Biology

Volumn 47, Issue 4, 2009, Pages 309-313

  Pendota, S C ^a   Grierson, D S ^a   Afolayan, A J ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

Antibacterial; Antifungal; Antimicrobial; Hippobromus pauciflorus

Indexed keywords

ACETONE; HIPPOBROMUS PAUCIFLORUS EXTRACT; METHANOL; PLANT EXTRACT; UNCLASSIFIED DRUG; WATER;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BARK; CONTROLLED STUDY; EYE INFECTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HIPPOBROMUS PAUCIFLORUS; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIUM; PENICILLIUM NOTATUM; PLANT LEAF; PLANT ROOT; PLANT STEM; SAPINDACEAE; SOUTH AFRICA;

ANIMALIA; ASPERGILLUS NIGER; BACTERIA (MICROORGANISMS); FUNGI; HIPPOBROMUS PAUCIFLORUS; NEGIBACTERIA; PENICILLIUM CHRYSOGENUM; POSIBACTERIA; SAPINDACEAE;

EID: 77149128711     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200902748445     Document Type: Article

References (37)

1. Afolayan AJ (2003): Extracts from the shoots of Arctotis artotoides inhibit the growth of bacteria and fungi. Pharm Biol 41: 22-25.
2. Afolayan AJ, Meyer JJM (1997): The antimicrobial activity of 3,5,7-trihydroxyflavone isolated from the shoot of Helichrysum aureonitens. J Ethnopharmacol 57: 177-181.
3. Bacq-Calberg CM, Coyotte J, Hoet P, Nguyem-Disteche M (1999): Microbiologie. Brussels, De Boeck & Larcier, p. 338.
4. Barreto M, Straker CJ, Critchley AT (1997): Short note on the effects of ethanolic extracts of selected South African sea weeds on the growth of commercially important plantpathogens, Rhizoctonia solani Kuhn and Verticullium sp. South African J Bot 63: 521-523.
5. Baquar SR (1995): The role of traditional medicine in rural environment. In: Issaq S, ed., Traditional Medicine in Africa. Nairobi, East Africa Educational Publishers, pp. 141-142.
6. Bryce K (1992): The Fifth Kingdom. Ontario, Mycologue Publications, pp. 937-938.
7. Clarkson C, Vinesh JM, Neil RC, Olwen MG, Pamisha P, Motlalepula GM, Niresh B, Peter JS, Peter IF (2004): In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa. J Ethnopharmacol 92: 177-191.
8. Cuong V, Michael O (2002): Staphylococcus epidermidis infections. J Microb Infect 4: 481-489.
9. Denning DW (1998): Invasive aspergillosis. J Clin Infect Dis 26: 781-803.
10. Diamond RD (1991): The growing problem of mycoses in patients infected with the human immunodefficiency virus. Rev Infect Dis 13: 480-486.
11. Drouhent E, Dupont B (1989): Fluconazole for the treatment of fungal diseases in immunosuppressed patients. Annals NY Acad Sci 544: 564-570.
12. Fabiana BM, Marangon DM, Joann AG, Eduardo CF (2004): In vitro investigation of voriconazole susceptibility for keratitis and endophalmitis fungal pathogens. Am J opthalmol 137: 820-825.
13. Goldstein MH, Kowalski RP, Gordon YJ (1999): Emerging fluoroquinolone resistance in bacterial keratitis: A 5-year review. J Ophthalmol 106: 1313-1318.
14. Grierson DS, Afolayan AJ (1999): Antibacterial activity of some indigenous plants used for the treatment of wound in the Eastern Cape. J Ethnopharmacol 66: 103-106.
15. Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW (2007): Aspergillus flavus human pathogen, allergen and mycotoxin producer. J Microbiol 153: 1677-1692.
16. Hirotoshi IB, Takashi S, Yoshiaki K, Kiyofumi O, Yasushi I, Wei Z, Mohammad MS, Yoshihiro KF, Yuichi O, Takayuki E (2006): Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections. J Diag Microbiol and Infect Dis 56: 297-303.
17. Koduru S, Grierson DS, Afolayan AJ (2006): Antimicrobial activity of Solanum aculeastrum. Pharm Biol 44: 283-286.
18. Kowalski RP, Pandya AN, Karenchak LM, Romanowski EG, Husted RC, Ritterband DC, Shah MK, Gordon YJ (2001): An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa. J Ophthalmol 108: 1826-1829.
19. Lanfranco G (1999): Invited review article on traditional medicine. Electr J Biotech 2: 1-3.
20. Levison WE, Jawetz E (1992): Medical Microbiology and Immunology, 2nd edn. New York, Appleton and Lange, pp. 61-310.
21. Lewu FB, Grierson DS, Afolayan AJ (2006): Extracts from Pelargonium sidoides inhibit the growth of bacteria and fungi. Pharm Biol 44: 279-282.
22. Marangon FB, Miller D, Muallem MS, Romano AC, Alfonso EC (2004): Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol 137: 453-458.
23. Marchese A, Shito GC (2001): Resistance patterns of lower respiratory tract pathogens in Europe. Int J Antimicr Agen 16: 25-29.
24. Masika PJ, Afolayan AJ (2003): An ethnobotanical study of plants used for the treatment of livestock diseases in the Eastern Cape Province, South Africa. PharmBiol 41: 16-21.
25. Mathekga ADM, Meyer JJM, Horn MM, Drews SE (2000): An acylated phloroglucinol with antimicrobial properties from Helichrysum caespititum. J Phytochem 53: 93-96.
26. Mathekga ADM, Meyer JJM (1998): Antibacterial activity of South African Helichrysum species. South African J Bot 64: 293-295.
27. Maurer-Grimes B, Mcbeth DL, Hallihan B, Delph S (1996): Antimicrobial activity inmedicinal plants of the Scrophulariaceae and Acanthaceae. Int J Pharmacog 34: 243-248.
28. Meyer JJM, Afolayan AJ (1995): Antibacterial activity of Helichrysum aureonitens (Asteraceae). J Ethnopharmacol 47: 109-111.
29. Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW (2005): Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation interim results of a prospective multicenter surveillance program. J Med Mycol 43: S49-S58.
30. Morrissey I, Burnett R, Viljoen L, Robbins M (2004): Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002. J Infect 49: 109-114.
31. Portillo A, Vila R, Freixa B, Adzet T, Canigueral S (2001): Antifungal activity of Paraguayan plants used in traditional medicine. J Ethnopharmacol 76: 93-98.
32. Rabe T, van Staden J (1997): Antibacterial activity of South African plants used for medicinal purposes. J Ethnopharmacol 56: 81-87.
33. Rasoanaivo P, Ratsimamanga-Urveg S (1993): Biological Evaluation of Plants with Reference to the Malagasy Flora. Monograph of the IFS-NAPRECA Workshop on Bioassays, Southern Book, Antananarivo, Madagascar, pp. 72-79.
34. Sindambiwe JB, Calomme M, Cos P, Totte J, Pieters L, Vlietinck A, vanden Berghe DA (1999): Screening of seven selected Rwandan medicinal plants for antimicrobial and antiviral activities. J Ethnopharmacol 65: 71-72.
35. Steel RGD, Torrie JH (1960): Principles and Procedures of Statistics. New York, McGraw-Hill, pp. 300.
36. Taylor RSL, Edel F, Manandhar NP, Towers GHN (1996): Antimicrobial activity of southern Nepalese medicinal plants. J Ethnopharmacol 50:97-102.
37. Quiroga EN, Sampietro AR, Vattluone MA (2001): Screening antifungal activities of selected medicinal plants. J Ethnopharmacol 74: 89-96.